Glioblastoma, one of the most aggressive primary brain tumors, has shown antigen loss in mice after treatment with anti-IL13Rα2-CAR.IL15 T cells due to downregulated IL13Rα2 expression [46]. This evidence concerns the gene IL13RA2 and glioblastoma.